Press Release

New Strategic Investment of IRICoR in RejuvenRx Spin-off

MONTRÉAL, January 27, 2023 – RejuvenRx Inc., an emerging biotechnology company developing novel small molecules-based targeted therapies focusing on stem cell biology, announced today a strategic investment from IRICoR, one of its co-founders. IRICoR, a Centre of Excellence in Commercialization … Read More